5-azacytidine treatment results in myelodysplastic syndrome

被引：0
|
作者：
Bakanay, S. M. [1 ]
Karakilic, E. [1 ]
Civriz-Bozdag, S. [1 ]
Arat, M. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Beksac, M. [1 ]
Konuk, N. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18003
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 5-Azacytidine for the treatment of myelodysplastic syndromes
    Krawczyk, Janusz
    Keane, Niamh
    Freeman, Ciara Louise
    Swords, Ronan
    O'Dwyer, Michael
    Giles, Francis J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1255 - 1268
  • [2] Treatment of myelodysplastic syndromes with 5-azacytidine
    Gryn, J
    Zeigler, ZR
    Shadduck, RK
    Lister, J
    Raymond, JM
    Sbeitan, I
    Srodes, C
    Meisner, D
    Evans, C
    LEUKEMIA RESEARCH, 2002, 26 (10) : 893 - 897
  • [3] Successful treatment of donor cell derived myelodysplastic syndrome with 5-azacytidine
    Jennane, Selim
    El Haddad, Mariyam
    Mahtat, El Mehdi
    Doghmi, Kamal
    Mikdame, Mohammed
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (06) : 713 - 714
  • [4] The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry
    Diamantopoulos, Panagiotis
    Koumbi, Dafni
    Kotsianidis, Ioannis
    Pappa, Vasiliki
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Zikos, Panagiotis
    Papadaki, Helen A.
    Panayiotidis, Panayiotis
    Dimou, Maria
    Hatzhnichael, Eleftheria
    Vassilopoulos, George
    Delimpasis, Susan
    Mparmparousi, Despoina
    Papageorgiou, Sotirios
    Variami, Eleni
    Kyrtsonis, Marie-Christine
    Megalakaki, Aekaterini
    Kotsopoulou, Maria
    Repousis, Panagiotis
    Adamopoulos, Ioannis
    Kontopidou, Flora
    Christoulas, Dimitrios
    Kourakli, Alexandra
    Tsokanas, Dimitrios
    Papoutselis, Menelaos Konstantinos
    Kyriakakis, Georgios
    Viniou, Nora-Athina
    CANCER MEDICINE, 2019, 8 (05): : 2056 - 2063
  • [5] TREATMENT OF PRIMARY AND THERAPY-RELATED MYELODYSPLASTIC SYNDROME WITH 5-AZACYTIDINE - COMPARATIVE RESULTS FROM A SINGLE CENTRE
    Augusto, J. S.
    Pierdomenico, F.
    Barroso, S.
    Almeida, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 357 - 357
  • [6] The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes
    Diamantopoulos, Panagiotis T.
    Symeonidis, Argiris
    Pappa, Vasiliki
    Kotsianidis, Ioannis
    Galanopoulos, Athanasios
    Pontikoglou, Charalampos
    Anagnostopoulos, Achilles
    Vassilopoulos, George
    Zikos, Panagiotis
    Hatzimichael, Eleftheria
    Papaioannou, Maria
    Megalakaki, Aekaterini
    Repousis, Panagiotis
    Kotsopoulou, Maria
    Dimou, Maria
    Solomou, Elena
    Dryllis, Georgios
    Tsokanas, Dimitrios
    Papoutselis, Menelaos-Konstantinos
    Papageorgiou, Sotirios
    Kyrtshonis, Marie-Christine
    Kourakli, Alexandra
    Papadaki, Helen
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (06) : 978 - 987
  • [7] Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre
    Montalvao, A.
    LEUKEMIA RESEARCH, 2013, 37 : S159 - S160
  • [8] Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
    Oran, Betul
    de Lima, Marcos
    Garcia-Manero, Guillermo
    Thall, Peter F.
    Lin, Ruitao
    Alousi, Amin M.
    Hosing, Chitra
    Kebriaei, Partow
    Popat, Uday
    Giralt, Sergio
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Andersson, Borje S.
    Bashir, Qaiser
    Ciurea, Stefan O.
    Rezvani, Katy
    Woodworth, Glenda
    Champlin, Richard E.
    BLOOD, 2018, 132
  • [9] The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry
    Diamantopoulos, Panagiotis Theodorou
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Zikos, Panagiotis
    Papadaki, Helen A.
    Panayiotidis, Panayiotis
    Dimou, Maria
    Hatzimichael, Eleftheria
    Vassilopoulos, George
    Delibasi, Sossana
    Mparmparousi, Despina
    Variami, Eleni
    Megalakaki, Aikaterini
    Kotsopoulou, Maria
    Repoussis, Panagiotis
    Adamopoulos, Ioannis
    Kontopidou, Flora
    Christoulas, Dimitrios
    Kourakli, Alexandra
    Tsokanas, Dimitrios
    Papoutselis, Menelaos Konstantinos
    Kyriakakis, Georgios
    Viniou, Nora-Athina
    BLOOD, 2017, 130
  • [10] RAPID HAEMATOLOGICAL RESPONSE WITH 5-AZACYTIDINE IN HIGH RISK MYELODYSPLASTIC SYNDROME
    Roy, J.
    Weston-Smith, S.
    Sahu, S.
    Grace, R.
    Dimitriadou, E.
    Nikolova, A.
    Rumbold, A.
    Gupta, S.
    HAEMATOLOGICA, 2013, 98 : 590 - 590
12345